Orient Pharma Co Stock Cash Flow From Operations
| 4166 Stock | TWD 37.95 0.35 0.93% |
Orient Pharma Co fundamentals help investors to digest information that contributes to Orient Pharma's financial success or failures. It also enables traders to predict the movement of Orient Stock. The fundamental analysis module provides a way to measure Orient Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orient Pharma stock.
Orient |
Orient Pharma Co Company Cash Flow From Operations Analysis
Orient Pharma's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Orient Pharma Cash Flow From Operations | (192.55 M) |
Most of Orient Pharma's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orient Pharma Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Orient Pharma Co has (192.55 Million) in Cash Flow From Operations. This is 136.52% lower than that of the Healthcare sector and 103.89% lower than that of the Drug Manufacturers - Major industry. The cash flow from operations for all Taiwan stocks is 119.83% higher than that of the company.
Orient Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orient Pharma's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orient Pharma could also be used in its relative valuation, which is a method of valuing Orient Pharma by comparing valuation metrics of similar companies.Orient Pharma is currently under evaluation in cash flow from operations category among its peers.
Orient Fundamentals
| Return On Equity | -14.97 | |||
| Return On Asset | -8.89 | |||
| Profit Margin | (61.79) % | |||
| Operating Margin | (79.63) % | |||
| Current Valuation | 3.23 B | |||
| Shares Outstanding | 156.01 M | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 10.53 X | |||
| Revenue | 285.29 M | |||
| Gross Profit | 5.66 M | |||
| EBITDA | (166.81 M) | |||
| Net Income | (176.29 M) | |||
| Cash And Equivalents | 64.58 M | |||
| Cash Per Share | 0.41 X | |||
| Total Debt | 287.34 M | |||
| Debt To Equity | 26.20 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 7.03 X | |||
| Cash Flow From Operations | (192.55 M) | |||
| Earnings Per Share | (1.13) X | |||
| Number Of Employees | 13 | |||
| Beta | 0.62 | |||
| Market Capitalization | 3 B | |||
| Z Score | 6.0 |
About Orient Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orient Pharma Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orient Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orient Pharma Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Orient Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orient Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Orient Stock
Moving against Orient Stock
| 0.88 | 4102 | Yung Zip Chemical | PairCorr |
| 0.76 | 4108 | Phytohealth Corp | PairCorr |
| 0.35 | 0051 | YuantaP shares Taiwan | PairCorr |
The ability to find closely correlated positions to Orient Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orient Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orient Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orient Pharma Co to buy it.
The correlation of Orient Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orient Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orient Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orient Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.